Investorideas.com newswire, breaking biotechnology and pharma news

Friday, May 14, 2021

New #Stocks to Watch at Investor Ideas in Biotech (CSE: $WESA.C) (Nasdaq: $LHDX) (Nasdaq: $VOR) and Mining (TSXV: $LOT.V) (TSXV: $CTM.V)

 New #Stocks to Watch at Investor Ideas in Biotech (CSE: $WESA.C) (Nasdaq: $LHDX) (Nasdaq: $VOR) and Mining (TSXV: $LOT.V) (TSXV: $CTM.V)

 

Also new stocks in Tech and Green Energy 

 

 


Point Roberts WA, Delta BC, May 14, 2021 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch in Biotech, Mining, Tech and Green Energy. Today’s stocks have been added to our lists of free stock directories in each sector.

 

Read this in full at  https://www.investorideas.com/news/2021/main/05141Stocks.asp

 

The newest biotech companies are involved in biopharmaceuticals, life sciences, stem cell therapies, COVID test kits and traumatic brain injury treatment using psychedelic and naturally-sourced therapies.

 

The latest mining companies are all TSX Venture listed.

 

The newest tech company is involved in the semiconductor sector while the latest green energy company is involved in the production of biofuels.

 

New Stocks added to Biotech Stocks Directory:

Vor Biopharma Inc.(NasdaqGS:VOR) is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells.

 

Terns Pharmaceuticals, Inc. (NasdaqGS:TERN) is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns’ programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients

 

Pharvaris N.V(NasdaqGS:PHVS) is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The Company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE.

 

Evaxion Biotech A/S (NasdaqGS:EVAX) is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer, bacterial diseases and viral infections. Based on its proprietary and scalable AI-immunology core technology, Evaxion is developing a broad pipeline of novel product candidates which currently includes three patient-specific cancer immunotherapies, two of which are in Phase 1/2a clinical development. In addition, Evaxion is advancing a portfolio of vaccines to prevent bacterial and viral infections currently in preclinical development.

 

Angion Biomedica Corp. (NasdaqGS:ANGNis committed to transforming the treatment paradigm for patients suffering from acute organ injuries and fibrotic diseases for which there are no approved medicines or where existing approved medicines have limitations. Angion’s lead product candidate, ANG-3777, is a hepatocyte growth factor (HGF) mimetic currently being evaluating in a Phase 3 registration trial for delayed graft function in patients undergoing deceased donor kidney transplantation, a Phase 2 trial in cardiac-surgery associated acute kidney injury, and a Phase 2 trial in patients with COVID-19 related pneumonia at high risk for acute respiratory distress syndrome. Angion is also currently evaluating ANG-3070, a tyrosine kinase receptor inhibitor for the treatment of fibrotic disease, in Phase 1. Additionally, Angion has preclinical programs for a rho kinase 2 (ROCK2) inhibitor and a CYP11B2 (aldosterone synthase) inhibitor.

 

Immunocore Holdings plc (NasdaqGS:IMCR) is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, infectious and autoimmune. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. Immunocore’s most advanced oncology therapeutic candidate, tebentafusp, has demonstrated an overall survival benefit in a randomized Phase 3 clinical trial in metastatic uveal melanoma, a cancer that has historically proven to be insensitive to other immunotherapies.

 

Bolt Biotherapeutics, Inc. (NasdaqGS:BOLT) is a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting precision of antibodies with the power of both the innate and adaptive immune systems Bolt’s proprietary Boltbody™ Immune-stimulating Antibody Conjugates (ISACs) approach uses immunostimulants to engage and activate myeloid cells that directly kill tumor cells. This leads to the conversion of immunologically “cold” tumors to “hot” tumors. Bolt’s lead candidate, BDC-1001, is a Boltbody ISAC comprised of a HER2-targeting biosimilar of trastuzumab conjugated to one of Bolt’s proprietary TLR7/8 agonists for the treatment of patients with HER2-expressing solid tumors. Bolt is also advancing additional Boltbody ISAC product candidates targeting CEA and PD-L1.

 

Defence Therapeutics Inc. (CSE:DTC)  is a biotechnology company engaged in the business of research and development, focusing on enhancing delivery of tumor-/ and infectious disease-specific therapeutics. The principal business carried on is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.

 

Theralink Technologies Inc. (OTC:OBMP) is a proteomics-based, molecular profiling and precision medicine company with a CLIA-certified laboratory located in Golden, Colorado. Through its unique and patented phosphoprotein and protein biomarker platform and LDTs, Theralink's technology targets multiple areas of oncology and drug development. Theralink provides precision oncology data through its powerful Theralink® Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both FDA-approved and investigational drug treatments. Theralink intends to help improve cancer outcomes for patients, help reveal therapeutic options for oncologists, and support biopharmaceutical drug development by using a beyond-genomics approach to molecular profiling that directly measures drug target levels and activity.

 

Lucira Health, Inc. (NasdaqGS:LHDX) is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular tests results anywhere and anytime. The LUCIRA CHECK IT (OTC) and LUCIRA COVID-19 All-In-One Test Kits (RX) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.

 

Wesana Health (CSE:WESA) is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury (TBI). Through extensive clinical research and academic partnerships, Wesana Health is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma.

 

New Stocks added to Mining Stocks Directory:

TomaGold Corp (TSX-V:LOT) is a Canadian mineral exploration corporation engaged in the acquisition, assessment, exploration and development of gold mineral properties. TomaGold has interests in five gold properties near the Chibougamau mining camp in northern Quebec: Obalski, Monster Lake East, Monster Lake West, Hazeur and Lac Doda. It also participates in a joint venture with Evolution Mining Ltd. and New Gold Inc., through which it holds a 24.5% interest in the Baird property, near the Red Lake mining camp in Ontario.

 

Canterra Minerals (TSXV: CTMOTC: CTMCF) is earning a 100% interest in the Wilding and Noel Paul Gold Projects, located 50km south, by logging road, from Millertown and directly northeast of Marathon Gold’s Valentine Lake Gold Project in Central Newfoundland. The 243km2 property package includes 50km of the northeastern strike-extension of the Rogerson Lake Structural Corridor, which hosts Marathon Gold’s Valentine Lake deposits, Matador Mining’s Cape Ray deposit, Sokoman’s Moosehead discovery and TRU Precious Metals’ Golden Rose and Twilight discoveries. A $2.75 million exploration program is underway, focusing on drilling and surface exploration on the Wilding Gold Project. This program will include additional diamond drilling on the existing zones and follow up trenching and diamond drilling on numerous targets identified from previous soil geochemistry sampling. Canterra’s team has more than 100 years of experience searching for gold and diamonds in Canada and have been involved in the discovery of the Snap Lake diamond mine, in addition to the discovery of the Blackwater Gold deposit in British Columbia, Canada.

 

Nevada Silver Corporation (TSXV: NSC) (TSXV: NBS.P) is a mineral exploration company with its material asset being the 100% owned Corcoran Canyon Silver Project in Nevada. The Corporation also holds a manganese project in Minnesota, USA.

 

New Stocks added to Tech Stocks Directory:

Transphorm Inc. (OTC:TGAN) a global leader in the GaN revolution, designs and manufactures high performance and high reliability GaN semiconductors for high voltage power conversion applications. Having one of the largest Power GaN IP portfolios of more than 1,000 owned or licensed patents, Transphorm produces the industry’s first JEDEC and AEC-Q101 qualified high voltage GaN semiconductor devices. The Company’s vertically integrated device business model allows for innovation at every development stage: design, fabrication, device, and application support. Transphorm’s innovations are moving power electronics beyond the limitations of silicon to achieve over 99% efficiency, 40% more power density and 20% lower system cost. Transphorm is headquartered in Goleta, California and has manufacturing operations in Goleta and Aizu, Japan

 

New Stocks added to Green Stocks Directory:

Taronis Fuels (OTC:TRNF) is a global producer of renewable and socially responsible fuel products. Taronis is dedicated to providing safe solutions to meet the industrial, commercial and residential needs of tomorrow’s global economy.

 

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.

We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

 

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining and the AI Eye.

 

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411



 

 


 

Tuesday, May 11, 2021

HEALTHMED SERVICES LTD (OTC: $HEME) Announces Appointment of New Director to its Board, @healthmedserv

 



 

HEALTHMED SERVICES LTD (OTC: $HEME) Announces Appointment of New Director to its Board, @healthmedserv

 

May 11, 2021, (investorideas.com Newswire) HEALTHMED SERVICES LTD, Palm Desert, California is quoted on the OTCmarkets under the ticker symbol “HEME

 

Read this in full at https://www.investorideas.com/news/2021/biotech/05111StockBites-HEME.asp

 

Recently the company management resigned and the company can today announce that a new OTC-experienced director has been found for the company and has been appointed to the board.


Newly engaged director is working with company's longtime accountant in order to bring the company financials current as soon as possible.

 

The company will in the nearest future be issuing additional information about its progress and encourage the investor community to follow press releases as well as the company Twitter account:

https://twitter.com/healthmedserv

 

Contact and source:

HEALTHMED SERVICES LTD.
74998 Country Club Drive. Suite 220-52

Palm Desert, CA 92260
www.HealthmedServicesLtd.com
info@HealthmedServicesLtd.com

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

 

Stock Bites is a branded product of Investorideas.com

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. This stock bites news release publication is  a paid for service on Investorideas.com  https://www.investorideas.com/News-Upload/ More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

 

Friday, May 7, 2021

New #Stocks to Watch at Investor Ideas in Technology (NasdaqGS: $SDH) (NYSE: $RAAS) (NasdaqGS: $BAOS), Biotech (CSE: $RYAH.C) and Green Energy (NasdaqCM: $CNEY)

 New #Stocks to Watch at Investor Ideas in Technology (NasdaqGS: $SDH) (NYSE: $RAAS) (NasdaqGS: $BAOS), Biotech (CSE: $RYAH.C) and Green Energy (NasdaqCM: $CNEY)

 

Also new stocks in Health & Wellness (CSE: $TAAT.C)(CSE: $PODA.C)


 

 

 

 


 

 

 

 

 

 

 

 

 

Point Roberts WA, Delta BC, May 7, 2021 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch in Tech, Biotech, Green Energy and Health & Wellness. Today’s stocks have been added to our lists of free stock directories in each sector.

 

Read this in full at https://www.investorideas.com/news/2021/main/05071Stocks.asp

 

The newest tech companies include new China stocks listed on Nasdaq/NYSE that are involved in cloud computing, mobile apps and internet advertising.

 

The latest biotech company is a life sciences company using tech, including AI for the plant-based medical industry.

 

The newest green energy company is involved in biomass in China while the latest Health & Wellness companies are involved in tobacco-free, healthier smoking products.

 

New Stocks added to Tech Stocks Directory:

Baosheng Media Group Holdings Ltd (NasdaqGS:BAOS) headquartered in Beijing, China, is an online marketing solution provider in China. The Company advises advertisers on online marketing strategies, offers value-added advertising optimization services and facilitates the deployment of online ads of various forms such as search ads, in-feed ads, mobile app ads and social media marketing ads. The Company is dedicated to helping its advertiser clients manage their online marketing activities with a view to achieving their business goals.

 

Cloopen Group Holding Ltd (NYSE:RAAS) is a leading multi-capability cloud-based communications solution provider in China offering a full suite of cloud-based communications solutions, covering communications platform as a service (CPaaS), cloud-based contact centers (cloud-based CC), and cloud-based unified communications and collaborations (cloud-based UC&C). The Company's mission is to enhance the daily communication experience and operational productivity for enterprises. The Company aspires to drive the transformation of enterprise communications industry by offering innovative marketing and operational tactics and SaaS-based tools.

 

Global Internet of People, Inc. (NasdaqGS:SDH) operates an online knowledge sharing and enterprise service platform, both online, via a mobile application “Shidonghui App” (the “APP”), and offline, through local offices in Beijing, Shanghai and Hangzhou, as well as 51 local centers operated by some of the Company’s members in 35 cities throughout the PRC. The main services SDH offers to App users are (1) Questions and Answers Sessions and (2) streaming of audio and video courses and programs. The offline services SDH offers to its members are study tours and forums

 

New Stocks added to Biotech Stocks Directory:

RYAH Group, Inc. (CSE:RYAH) is a company operating out of New York, which, directly and through its wholly-owned subsidiary RYAH Medtech Inc., is engaged in the development and commercialization of various innovative technology solutions (both software and hardware) for the plant-based medical industry. Since its formation, RYAH Group Inc. has been focused on leveraging its know-how in predictive analytics to pioneer products to be used within its suite of vertically-integrated technologies, to provide users with added control over their health and wellness. As an emerging company, RYAH Group, Inc. is striving to establish itself as a leader in delivering innovative, user-friendly IoT devices in the plant-based medical industry. By utilizing its know-how in fields such as artificial intelligence and predictive analytics, Potbotics is moving towards building a portfolio of vertically-integrated products that facilitate harmonized data collection throughout the complete medical plant lifecycle, from seed to consumption

 

New Stocks added to Green Stocks Directory:

CN ENERGY GROUP. INC. (NasdaqCM:CNEY) is a China-based manufacturer and supplier of wood-based activated carbon and a producer of biomass electricity. The Company also provides activated carbon related technical services. Its wood-based activated carbon is primarily used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production.

 

New Stocks added to Health & Wellness Stocks Directory:

TAAT Global Alternatives Inc.(CSE:TAAT) has developed TAAT™, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in "Original", "Smooth", and "Menthol" varieties. TAAT™'s base material is Beyond Tobacco™, a proprietary blend which undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with "Big Tobacco" pedigree, TAAT™ was launched first in the United States in Q4 2020 as the Company seeks to position itself in the $814 billion1 global tobacco industry.

 

Poda Lifestyle and Wellness Ltd. (CSE: PODA) is actively engaged in the global commercialization of HNB smoking products, which have the potential to reduce the risks associated with combustible smoking products. The Company has developed a patented HNB system that uses proprietary biodegradable single-use pods, which are both consumer and environmentally friendly. The innovative design of the Company’s HNB platform prevents cross-contamination between the heating devices and the pods, eliminating all cleaning requirements and providing users with the most convenient and enjoyable potentially-reduced-risk smoking experience. Poda Lifestyle’s HNB system is fully patented in Canada and is patent pending in 65 additional countries, covering over 70% of the global population. The Company’s Poda Pods are the first and only cigarettes to have a completely closed end. This exclusive design entirely eliminates all cleaning requirements and provides a truly ashless HNB cigarette. Poda Lifestyle’s fully-patented system is truly one of a kind and solves the major pain-point that ALL other HNB products suffer from: daily cleaning requirements. The Company’s flagship Beyond Burn™ Poda Pods contain a unique tobacco-free blend of pelletized tea leaves infused with synthetic nicotine, which provides adult smokers with a smoke-free alternative to their regular habit without sacrificing the satisfaction they are accustomed to. Beyond Burn™ Poda Pods have been expertly crafted to mimic the sensorial experience of traditional cigarettes without the smoke, without the smell, and without the tobacco.

 

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.

We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

 

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining and the AI Eye.

 

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 


 


Tuesday, May 4, 2021

#AI #Health #Stock News -GBT (OTC: $GTCH) Commences Research on an External Device for Arterial Clogs and Tissue Imaging

 #AI #Health #Stock News -GBT (OTC: $GTCH) Commences Research on an External Device for Arterial Clogs and Tissue Imaging

 

#Technology Based on its Proprietary Radio Technology

 


San Diego, CA, May 4, 2021 -
 (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) is researching an external device for arterial and tissue imaging based on its proprietary radio technology, combined with the company’s robotic research. The research contemplates an external unit targeted to be operated with a robotic arm to scan designated bodily areas and provide an image of arteries and tissues.

 

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/05041External-Device.asp

 

The main advantage of the contemplated system is its pure non-invasive nature. The research is part of the Hermes capsule research project.  The Hermes capsule research targets an intravenous mini-probe unit that travels within the artery, searching to find arterial clogs. Hermes unit is based on radio waves-based imaging to produce a computerized 3D imaging for the operating physician. The unit is contemplated to be AI empowered, non-surgical, minimally invasive, safe method for autonomous and/or manual blood vessels blockage detection and cleaning. The research is focused on developing a complementary unit, which is an external probe is targeted to provide more imaging information for arterial and tissue imaging. The research is examining an external probe that will scan the designated body area that can be mounted on an AI controlled robotic arm, and use radio wave technology to provide 3D imaging of arteries/tissues on a computer screen for a physician review. The research is also evaluating a manually used external probe, as a hand-held unit, similar to typical ultrasound units. The main purpose of the external unit would be to enable external tissue and arterial AI based imaging with great depth and resolution. The external unit will be a combined work of GBT’s medical robotic and Hermes capsule imaging research.

 

"We are aiming for further advancements for health-related applications and we believe the contemplated external imaging system would add significant advantage, tissue imaging in addition to arterial view. As our Hermes capsule research is targeting to “look ahead” inside arteries, the external device is a combination of our medical robotics and Hermes capsule research to enable a completely non-invasive imaging system, very similar to typical ultrasound units. The research is focused on an external device using radio waves technology that will be transmitted into a designated bodily area for arterial and tissue imaging. Few methods of imaging will be explored to achieve a clear, high resolution 3D shots. It is contemplated as a real time 2D/3D images of the inner blood vessels and tissues using our AI image construction. The system is intended to be able to differ between tissues, organs and clogging materials as well as identifying tumors, Cysts and other foreign objects. In addition, using the radio technology the system will be able to construct a 3D video imaging of the scanned areas. The probe will be able to be mounted on a robotic arm to hover above designated bodily areas or manually held for more specific areas scan. The system will be using GBT’s AI technology and we strongly believe that it has the potential become a key apparatus within surgery rooms and clinics as a physician’s “eyes” helping savings lives” stated Danny Rittman, GBT’s CTO.

 

There is no guarantee that the Company will be successful in researching, developing or implementing this system.  To successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed, and granted regulatory approval, the Company would need to enter a strategic relationship with a third party that has experience in manufacturing, selling, and distributing this product.  There is no guarantee that the Company will be successful in any or all of these critical steps. 

 

External Device a conceptual Image.

 

 



 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

 

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 


  Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

 

 

Thursday, April 29, 2021

#AI #Health #Stock News: GBT Tokenize (OTC: $GTCH) achieved viable Kirlian Electrophotography techniques conclusions; #artificialintelligence

 #AI #Health #Stock News: GBT Tokenize (OTC: $GTCH) achieved viable Kirlian Electrophotography techniques conclusions; #artificialintelligence

 

Moving into investigation of possible #health-related correlations

 


SAN DIEGO - April 29, 2021 (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT" or the "Company"), announced that GBT Tokenize ("GBT/Tokenize) achieved viable Kirlian Electrophotography techniques conclusions and is now investigating possible health related correlations and application implementations. The Kirlian techniques potentially aimed for inclusion within its qTerm device, are based on the phenomenon known as electrical coronal discharge. Images that are taken using these techniques present a colorful so-called aura which can be interpreted in a variety of ways. The human body emits various radiations such as electromagnetic radiation, infrared, low level visible light and ultraviolet radiation. All these emissions are part of the human energy field, also called the biofield. This human biofield carries unique information which may be useful for diagnosing or predicting early health conditions and symptoms. GBT's research is focused on the investigation of Kirlian images with the use of machine learning technology to possibly detect early disease symptoms. GBT's research within this domain included imaging analytics and graphical experiments in attempt to achieve findings to correlate auras with possible medical symptoms. Using advanced imaging algorithms, Kirlian images were analyzed for patterns, associated colors and shapes. Kirlian imaging produces features such as graphical protuberances, halos, and discharge patterns, which were analyzed and categorized as a possible criterion. GBT believes it has reached viable graphical results and will now move into checking possible health related correlations and implementations. GBT plans to further experiment to analyze energy fields generated by living organs and based on future conclusions will evaluate the implementation of such techniques within its qTerm human vitals product to provide further vital health information.

 

Read this news featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/04291Kirlian-Electrophotography.asp

 

"We believe we have reached a viable conclusion with our Kirlian electrophotography imaging research and intend to now move to check correlations possibilities for detecting early disease symptoms or conditions. It is believed that Kirlian images of a living tissue produce energy level called auras. We graphically analyzed these images and reached some consistent findings. We plan to further investigate the possibility to determine about the identification of onset health issues that are reflected by image's colors and patterns. An AI engine will be further analyzing unique patterns with the goal of finding association with health symptoms. We will look for full and partial similarities, repetitions, or atypical auras patterns. Each image will be digitized and pixelized to categorize patterns/colors and to get a comparative analysis between images. We will investigate body's organs radiations, their graphical representation, and possible connection with health-related topics. Upon further research and conclusions, we intend to evaluate possible implementation of such technology within our qTerm device to enable further health related advice. Our goal is to use this research to offer an extraordinary vital health related information that may benefit individuals, scientists, and physicians." Said Danny Rittman, the Company's CTO.

There is no guarantee that the Company will be successful in researching, developing or implementing this system. In order to successfully implement this system, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) ("GBT") (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT's mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT's goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT's vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

 

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 


  Get more tech stocks investor ideas- news, articles, podcasts and stock directories